Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Mikell

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
EJNMMI Physics|December 21, 2022
Intra- and inter-operator variability in MRI-based manual segmentation of HCC lesions and its impact on dosimetryElise C Covert, Kellen Fitzpatrick, Justin Mikell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2021
Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After <sup>90</sup>Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of HepatotoxicityMatthew M Cousins, Theresa P Devasia, Christopher M Maurino, et al.
Frontiers in Oncology|August 22, 2024
Arterial hypoperfusion as a negative predictive marker for primary hepatic malignancies treated with Y-90 glass microsphere transarterial radioembolizationBita Kalaghchi, Semra Ince, Justin Barnes, et al.
Brachytherapy|May 22, 2022
The American Brachytherapy Society consensus statement for permanent implant brachytherapy using Yttrium-90 microsphere radioembolization for liver tumorsNavesh K Sharma, S Cheenu Kappadath, Michael Chuong, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
EJNMMI Physics|December 21, 2022
Intra- and inter-operator variability in MRI-based manual segmentation of HCC lesions and its impact on dosimetryElise C Covert, Kellen Fitzpatrick, Justin Mikell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2021
Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After <sup>90</sup>Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of HepatotoxicityMatthew M Cousins, Theresa P Devasia, Christopher M Maurino, et al.
Frontiers in Oncology|August 22, 2024
Arterial hypoperfusion as a negative predictive marker for primary hepatic malignancies treated with Y-90 glass microsphere transarterial radioembolizationBita Kalaghchi, Semra Ince, Justin Barnes, et al.
Brachytherapy|May 22, 2022
The American Brachytherapy Society consensus statement for permanent implant brachytherapy using Yttrium-90 microsphere radioembolization for liver tumorsNavesh K Sharma, S Cheenu Kappadath, Michael Chuong, et al.
Pageof 2